ASX
Clarity Pharmaceuticals Ltd
CU6:ASX•Healthcare
Sensitive ASX Announcement
IND approval from the FDA for theranostic SAR-Bombesin trial
Published: 21/11/22, 09:50am (AEST)•3 pages